These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. 99mTc-labelled pyrophosphate myocardial scanning in experiment and in clinical practice. Vizda J; Duska F; Kubícek J; Kafka P; Novák J; Mazurová Y Cor Vasa; 1981; 23(6):457-66. PubMed ID: 6277567 [TBL] [Abstract][Full Text] [Related]
25. [Pyrophosphate scan of the heart in cardiomyopathies (author's transl)]. Duska F; Novák J; Kubícek J; Vizda J; Kafka P; Blaha V; Nesvadba Z; Zdánský P Cesk Radiol; 1982 Jan; 36(1):40-7. PubMed ID: 6284387 [No Abstract] [Full Text] [Related]
26. Daunorubicin-induced chronic cardiomyopathy--an experimental model system for study of sudden death. A preliminary report. Rajs J; Isberg B; Paul C; Ahlberg NE Forensic Sci Int; 1982; 20(3):217-25. PubMed ID: 6292058 [No Abstract] [Full Text] [Related]
27. Technetium-99m-pyrophosphate uptake as an indicator of myocardial injury without infarct. Okuda K; Nohara R; Fujita M; Tamaki N; Konishi J; Sasayama S J Nucl Med; 1994 Aug; 35(8):1366-70. PubMed ID: 8046495 [TBL] [Abstract][Full Text] [Related]
28. [Comparison of pyrophosphate and gluconate scans of the heart in dogs with experimental cardiomyopathy]. Duska F; Novák J; Kafka P; Kubícek J; Vizd'a J; Mazurová Y; Veverková O Vnitr Lek; 1983 Apr; 29(4):338-44. PubMed ID: 6306923 [No Abstract] [Full Text] [Related]
29. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis. Gertz MA; Brown ML; Hauser MF; Kyle RA Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031 [TBL] [Abstract][Full Text] [Related]
30. Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis. Janssen S; Piers DA; van Rijswijk MH; Meijer S; Mandema E Eur J Nucl Med; 1990; 16(8-10):663-70. PubMed ID: 2166666 [TBL] [Abstract][Full Text] [Related]
31. Comparison of early myocardial technetium-99m pyrophosphate uptake to early peaking of creatine kinase and creatine kinase-MB as indicators of early reperfusion in acute myocardial infarction. Kondo M; Yuzuki Y; Arai H; Shimizu K; Morikawa M; Shimono Y Am J Cardiol; 1987 Oct; 60(10):762-5. PubMed ID: 2821787 [TBL] [Abstract][Full Text] [Related]
32. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis]. Volpi A; Cavalli A; Maggioni AP; Inglese E; Rovelli GE; Neri R; Salvi A G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892 [TBL] [Abstract][Full Text] [Related]
35. Increased incidence and clinical correlation of persistently abnormal technetium pyrophosphate myocardial scintigrams following acute myocardial infarction in patients with diabetes mellitus. Nicod P; Lewis SE; Corbett JC; Buja LM; Henderson G; Raskin P; Rude RE; Willerson JT Am Heart J; 1982 May; 103(5):822-9. PubMed ID: 6280468 [TBL] [Abstract][Full Text] [Related]
36. Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy. Hongo M; Hirayama J; Fujii T; Yamada H; Okubo S; Kusama S; Ikeda S Am Heart J; 1987 Mar; 113(3):654-62. PubMed ID: 3030086 [TBL] [Abstract][Full Text] [Related]